Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
USA Rare Earth Announces Closing of $75 Million PIPE Financing
-
BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update
-
Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scie
-
Microbix’s Clot-Buster Drug Project Advances
-
Update to Zijin Put Option and Exclusivity Arrangements
-
Asante Projects Transformative Growth in Updated Five-Year Outlook: 500,000+ oz Annual Gold Production by 2028, >$2 Billion in Free Cash Flow, Increased Mineral Reserves
-
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
-
Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events
-
As Federal Collections Activity Resumes, More Than One in Five Federal Student Loan Borrowers With a Payment Due are Seriously Delinquent
-
MTY Food Group Inc. Announces Results from 2025 Annual General Meeting
-
Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspé Project
-
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®
-
Apollo Silver Appoints Ross McElroy as President and CEO
-
Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September
-
PLBY Group to Report First Quarter 2025 Financial Results on May 15, 2025
-
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
-
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
-
Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial
-
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
-
Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company
-
Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events
-
Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
Grassy Mountain Gold Project Selected for US Government FAST-41 Program
-
ManageMy and Solvrays Enable Insurance Carriers to Automate Workflows and Deliver Better Customer Experiences
-
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
-
AAFA Calls on Congress to Restore Lifesaving National Asthma Control Program
-
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
-
Algorhythm Holdings Acquires SemiCab India, Expands Global AI Transportation Footprint
-
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
-
GXO and Blue Yonder Announce New Strategic Global Agreement
-
EnviroGold Global Announces Appointment of Paul McRae as Non-Executive Chair
-
Colliers adds leading telecommunications engineering firm
-
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
-
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
-
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
-
Q1 Report Fenix Outdoor International AG
-
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
-
AKVA group ASA: New land based contract signed
-
Dundee Precious Metals Announces Passing of Chair R. Peter Gillin
-
BioNTech Announces First Quarter 2025 Financial Results and Corporate Update
-
Descartes Sets Date to Announce First Quarter Fiscal 2026 Financial Results
-
Freshpet, Inc. Reports First Quarter 2025 Financial Results
-
Hyperscale Data Announces Preliminary $25 Million in Revenue for Q1 2025, Provides Full-Year Guidance of $115–$125 Million
-
FTAI Aviation Ltd. to Participate in the Barclays Americas Select Franchise Conference 2025
-
Integra LifeSciences Reports First Quarter 2025 Financial Results
-
Kalmar Corporation - Managers' Transactions - Bono
-
Kalmar Corporation - Managers' transactions - Torttila-Miettinen
-
Kalmar Corporation - Managers' transactions - Pohjonen
-
Kalmar Corporation - Managers' transactions - Lindholm
-
Kalmar Corporation - Managers' transactions - Laisi
